Product logins

Find logins to all Clarivate products below.


The Japanese ENT device market is projected to grow at a modest pace over the forecast period, supported by a slight increase in ENT procedure volumes. This growth will be primarily driven by a rise in FESS procedure volumes, with the flexible scope, powered instrument, and nasal packing markets expected to see relatively faster growth.

This Medtech 360 Report provides comprehensive data and analysis on the state of the ENT device market in Japan from 2019 through 2034.

The number of ENT procedures performed will only grow marginally through 2034.

Which procedure types are seeing a decline, and which ones are growing?

What are the trends driving or limiting the growth of the various ENT procedure types in Japan?

How will the dynamics across ENT procedure types ultimately impact market growth?

The presence of competitors across multiple market segments impacts their positions in the ENT market.

What are the benefits for companies operating in multiple market segments within the Japanese ENT market?

How does operating in multiple segments allow companies to leverage synergies in the ENT market?

The adoption of premium-priced products is driving growth in the Japanese ENT device market.

In which device segments are premium-priced products available?

How is the demand for premium-priced ENT devices influencing overall market growth in Japan?

Which products will see increasing physician adoption during the forecast period?

Table of contents


Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Latin America
The Latin American biosurgical agent market will grow modestly through 2034; although demand for biosurgical agents will rise—supported by favorable regional demographics, expanded indication…
Report
Biosurgical Agents – Market Insights – US
The biosurgical agent market in the US will experience modest growth through 2034. This growth will be fueled by rising surgical procedure volumes that require biosurgical agent and strong…
Report
Biosurgical Agents – Market Insights – Japan
The Japanese biosurgical agent market is projected to demonstrate a modest growth through 2034, driven by the rising volume of surgical procedures, increasing physician awareness of the clinical…
Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…